Northern New Jersey Cancer Associates — Hackensack, New Jersey

Northern New Jersey Cancer Associates is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Northern New Jersey Cancer Associates has participated in 4 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Peripheral T-cell Lymphoma, Acute Myeloid Leukemia (AML).

Sponsors: Jazz Pharmaceuticals, Spectrum Pharmaceuticals, Inc, Clavis Pharma.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northern New Jersey Cancer Associates?

Northern New Jersey Cancer Associates has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northern New Jersey Cancer Associates conducted?

Northern New Jersey Cancer Associates has 4 clinical trials on record. Their work covers Acute Myeloid Leukemia, Peripheral T-cell Lymphoma, Acute Myeloid Leukemia (AML).

Is Northern New Jersey Cancer Associates accredited by Crixeo Health?

Northern New Jersey Cancer Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northern New Jersey Cancer Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.